Treace CEO buys 50,000 company shares
Treace Medical Concepts Chief Executive Officer John T. Treace purchased 50,000 shares of common stock in an open-market transaction on June 1, 2026 at a weighted average price of $3.5583 per share, with individual prices ranging from $3.51 to $3.60.
Rhea-AI Filing Summary
Treace Medical Concepts Chief Executive Officer John T. Treace purchased 50,000 shares of common stock in an open-market transaction on June 1, 2026 at a weighted average price of $3.5583 per share, with individual prices ranging from $3.51 to $3.60.
Following this purchase, he directly holds 7,323,833 shares of common stock, which includes 542,784 restricted stock units. He also reports additional indirect holdings through various trusts and his spouse, while expressly disclaiming beneficial ownership of those indirectly held shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 50,000 shares
Net Buy
5 txns
Insider
Treace John T.
Role
Chief Executive Officer
Bought
50,000 shs ($178K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 50,000 | $3.5583 | $178K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 7,323,833 shares (Direct);
Common Stock — 1,605,000 shares (Indirect, By spouse);
Common Stock — 1,471,250 shares (Indirect, By spouse as trustee of a trust);
Common Stock — 1,839,063 shares (Indirect, As trustee of a trust);
Common Stock — 408,816 shares (Indirect, As co-trustee of a trust)
Footnotes (4)
- F1. The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.5100 to $3.6000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F2. Includes 542,784 restricted stock units.
- F3. The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
- F4. The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
Key Figures
Shares purchased: 50,000 shares
Weighted average price: $3.5583 per share
Price range: $3.51–$3.60 per share
+5 more
8 metrics
Shares purchased
50,000 shares
Open-market purchase on June 1, 2026
Weighted average price
$3.5583 per share
Price for 50,000-share open-market purchase
Price range
$3.51–$3.60 per share
Range of individual trade prices for purchased shares
Direct holdings after purchase
7,323,833 shares
Common stock directly owned by CEO after transaction
Restricted stock units included
542,784 RSUs
Restricted stock units included in direct holdings
Indirect holding as co-trustee
408,816 shares
Common stock held in trust where CEO is co-trustee
Indirect holding as trustee
1,839,063 shares
Common stock held in trust where CEO is trustee
Spouse-related indirect holdings
1,471,250 and 1,605,000 shares
Common stock held by spouse and spouse as trustee
Key Terms
open-market purchase, weighted average purchase price, restricted stock units, beneficial ownership, +1 more
5 terms
open-market purchase financial
"Purchase in open market or private transaction"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average purchase price financial
"The price reported in Column 4 is a weighted average purchase price."
The weighted average purchase price is the average cost per share you paid across multiple buys, calculated so larger purchases count more than smaller ones. Imagine buying apples at different prices: the overall price you effectively paid depends on how many apples you bought at each price. Investors use it to measure true cost basis, calculate gains or losses, decide when to sell, and manage taxes and portfolio performance.
restricted stock units financial
"Includes 542,784 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of shares held by his wife"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
co-trustee of a trust financial
"As co-trustee of a trust"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did TMCI CEO John T. Treace do in this Form 4 filing?
John T. Treace reported buying 50,000 shares of Treace Medical Concepts common stock in an open-market transaction. This increases his direct equity stake and reflects additional personal capital committed at prices between $3.51 and $3.60 per share.
What are John T. Treace’s direct TMCI holdings after this transaction?
After the purchase, John T. Treace directly owns 7,323,833 shares of Treace Medical Concepts common stock. This figure includes 542,784 restricted stock units, which typically represent share-based compensation that may settle in stock over time.
What does the filing say about restricted stock units for TMCI’s CEO?
The filing states that Treace’s direct holdings include 542,784 restricted stock units. Restricted stock units are share-based awards that generally vest over time, potentially converting into common shares and further aligning executive compensation with shareholder outcomes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
